Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_assertion wasGeneratedBy ECO_0000203 NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_assertion wasDerivedFrom befree-20140225 NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_assertion SIO_000772 18048643 NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_assertion evidence source_evidence_literature NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_assertion description "[Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.
- befree-20140225 importedOn "2014-02-25" NP800416.RA6OXXDgfSHLUzneIew-XqFShnakX6h6NzD5unNHaIS5M130_provenance.